Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangrun Health Industry (Hong Kong) Co. Limited
Hong Kong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Guangrun Health Industry (Hong Kong) is a Hong Kong–based healthcare investment company that led the $75M Series D financing of clinical-stage biotech Arthrosi Therapeutics in 2023.
- Industry
- Investors
02
Partnerships
Lead investor in Arthrosi Therapeutics $75M Series D financing round (2023)
Beyond the preview
Go deeper on Guangrun Health Industry (Hong Kong) Co. Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangrun Health Industry (Hong Kong) Co. Limited.